A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype

Abstract

We report the first case of holoprosencephaly in association with MTX exposure during the first 6 weeks of gestation. Physicians and the public should be aware of the effects of MTX on the fetus during pregnancy.